Friday, 10 Apr 2020

You are here

Venom Peptide-Steroid Conjugate Effective in Collagen Induced Arthritis

Science Translational Medicine features a report from the Fred Hutchinson Cancer Research Center showing that a scopion venom peptide, coupled to steroid, can significantly reduce joint inflammation in a rat model of rheumatoid arthritis (RA).

Using a peptide shown to traffic to joint cartilage, researchers systemically treated rodents with collagen-induced arthritis, with a conjugate of the peptide with steroid, suggesting that such a conjugate has the potential for joint-targeted therapy.

Cystine-dense peptides (CDPs) were shown to distribute to cartilage of the knees, ankles, hips, shoulders, and intervertebral discs, achieving peak concentration in cartilage within 30 min (after after systemic administration) and remained detectable for >4 days.

CDPs are miniproteins defined by having at least three disulfide bonds (cystines) in a protein that is typically 20 to 60 amino acids in length. CDPs may be found in the venom of spiders, snakes, scorpions and a wide variety of other species, including plants, fungi, bacteria, marine mollusks, and insects. 

In these studies they used, CDP-11R, that was shown to distribute (by fluorophore imaging) to joint cartilage when coupled with either dexamethasone or triamcinolone acetonide (TAA).

The CDP-11R–TAA conjugate was superior in alleviating joint inflammation in the rat collagen–induced model while avoiding toxicities.

This conjugate shows promise for clinical development and establishes proof of concept for multijoint targeting of disease-modifying therapeutic payloads.

The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

The Immunologic Basis of Wellness in the COVID-19 Era

We indeed are living in interesting times and we all are seeking not to contract COVID-19 - this is logical. While our goal is to avoid infection, I think we all must agree that our aspirations must encompass more than disease avoidance. What we should be seeking now, as well, is more than absence of disease but rather a state of optimal wellness.

COVID Town Hall Meeting for Rheumatology

On Thursday, April 2nd, RheumNow hosted its' first Town Hall Meeting for Rheumatologist, with this 90 minute discussion devoted to the COVID-19 crisis as it affects Rheumatologists. 

The panel of six reknowned experts in rheumatology, practice, science, trials, telemedicine and infectious diseases included:

Universal Masking for COVID?

In early March 2020, there were widespread recommendations that wearing routine "surgical masks" by the public sector was not likely to be helpful or advisable. Now we are hearing of a 180 degree shift in thinking with the CDC, leading health officials and the current NEJM Perspective pointing to more widespread use of masks by healthcare workers and even by individuals in the public sector.

COVID Infection Run Down with Dr. Kevin Winthrop

Dr Kevin Winthrop answers COVID questions and advocates for "hit the pause button, lay low and exercise". We discuss the utility of baricitinib, losartan, COVID testing, Next Success and who to listen to.

Dr. Artie Kavanaugh - Don't Stop!

Drs. Cush and Kavanaugh discuss the downside of stopping hydroxychloroquine, DMARDs and biologics in lupus, RA and pregnancy.